Form4.ai tracks every SEC insider trade in real time. See every CUE insider filing with a free account — no card.
See every CUE insider filing — free account, no card.
Free accountCue Biopharma, Inc. (CUE) has 8 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $389K. Most recent filing: Oct. 14, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 14, 2026 SEC filing | Ray Sumita Chief Legal Compliance Officer | Sold | $51,724 | — |
| Oct 14, 2026 SEC filing | Meluzio Michael Vincent VP, Prin. Accounting Officer | Sold | $32,089 | — |
| Oct 14, 2026 SEC filing | Lin Shao-Lee Chief Executive Officer | Sold | $305,490 | — |
Create a free account to see all 8 CUE filings from the last 90 days. No card needed.
Create free accountWant CUE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.